Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

An integrated view of the role of the B cell antigen receptor in lymphoma cell fitness

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.12.18
Views: 462

Dr Stefano Casola - Institute of Molecular Oncology Foundation, Milan, Italy

Dr Stefano Casola speaks to ecancer at ASH 2018 about the role of the B cell antigen receptor in metabolism in malignant cells.

He explains that it was discovered through animal models that when the B cell receptor is lost the cells learn to adapt and use other ways to survive.

Dr Casola outlines that there has been a large scale screening for FDA approved drugs that can target and kill these cells meaning if such a drug is found clinical trials can begin immediately.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation